Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
- PMID: 9059986
- DOI: 10.1023/a:1006883924775
Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Abstract
Tau protein from Alzheimer disease (AD) brain is hyperphosphorylated by both proline-dependent protein kinases (PDPKs) and non-PDPKs. It is presently unclear how PDPKs and non-PDPKs interact in tau hyperphosphorylation. Previously we have shown that non-PDPKs can positively modulate the activity of a PDPK (GSK-3) in tau phosphorylation (Singh et al. (1995) FEBS Lett. 358, 267-272). In this study we have investigated whether (A) non-PDPKs can also modulate the activity of the PDPK, cdk5, (B) a PDPK can modulate the activities of another PDPK, as well as non-PDPKs. We found that, like GSK-3, the activity of cdk5 is stimulated if tau were first prephosphorylated by any of several non-PDPKs (A-kinase, C-kinase, CK-1, CaM-kinase II). Prephosphorylation of tau by cdk5 stimulated both the rate and extent of a subsequent phosphorylation catalyzed by GSK-3. Under these conditions thr 231 phosphorylation was especially enhanced (9-fold). No significant stimulation of phosphorylation was observed when the order of these kinases was reversed (i.e. GSK-3 followed by cdk5). By contrast, prephosphorylation of tau by cdk5 served to inhibit subsequent phosphorylation catalyzed by C-kinase and CK-1, but not by A-kinase or CaM-kinase II. Our results suggest that in tau hyperphosphorylation in AD brain, cdk5-catalyzed phosphorylation may serve to upregulate the activity of GSK-3 and down-regulate the activities of C-kinase and CK-1.
Similar articles
-
Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3.FEBS Lett. 1995 Jan 30;358(3):267-72. doi: 10.1016/0014-5793(94)01445-7. FEBS Lett. 1995. PMID: 7531159
-
Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain.Mol Cell Biochem. 1996 Jan 26;154(2):143-51. doi: 10.1007/BF00226782. Mol Cell Biochem. 1996. PMID: 8717428
-
Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases.FEBS Lett. 1995 Jan 16;358(1):4-8. doi: 10.1016/0014-5793(94)01383-c. FEBS Lett. 1995. PMID: 7821426
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
-
Tau therapeutic strategies for the treatment of Alzheimer's disease.Curr Top Med Chem. 2006;6(6):579-95. doi: 10.2174/156802606776743057. Curr Top Med Chem. 2006. PMID: 16712493 Review.
Cited by
-
GSK-3: Functional Insights from Cell Biology and Animal Models.Front Mol Neurosci. 2011 Nov 16;4:40. doi: 10.3389/fnmol.2011.00040. eCollection 2011. Front Mol Neurosci. 2011. PMID: 22110425 Free PMC article.
-
Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.Curr Med Sci. 2020 Dec;40(6):1009-1021. doi: 10.1007/s11596-020-2282-1. Epub 2021 Jan 11. Curr Med Sci. 2020. PMID: 33428128 Review.
-
A novel calcium-binding protein is associated with tau proteins in tauopathy.J Neurochem. 2008 Jul;106(1):96-106. doi: 10.1111/j.1471-4159.2008.05339.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18346207 Free PMC article.
-
Physiological and pathological phosphorylation of tau by Cdk5.Front Mol Neurosci. 2014 Jul 15;7:65. doi: 10.3389/fnmol.2014.00065. eCollection 2014. Front Mol Neurosci. 2014. PMID: 25076872 Free PMC article. Review.
-
Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level.FEBS Lett. 2006 Oct 30;580(25):5925-33. doi: 10.1016/j.febslet.2006.09.060. Epub 2006 Oct 5. FEBS Lett. 2006. PMID: 17045592 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials